Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Archive
Search for this keyword
Advanced search
Close
More
Main menu
Archive
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 82, Issue Suppl 1
AB0239 THE REDUCTION OF CIRCULATING LEVELS OF SERUM CALPROTECTIN IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT
Email alerts
Alerts
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Scientific Abstracts
Publication only
Rheumatoid arthritis - prognosis, predictors and outcome
AB0239 THE REDUCTION OF CIRCULATING LEVELS OF SERUM CALPROTECTIN IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
User Name
*
Password
*
Sign In to Email Alerts with your Email Address
Email
*
Read the full text or download the PDF:
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF